Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ADAP | Adaptimmune Therapeutics PLC | Director | $50.5K | Jul 1, 2024 | ||
BDTX | Black Diamond Therapeutics, Inc. | Director | Jun 6, 2024 | |||
STOK | Stoke Therapeutics, Inc. | Director | Jun 5, 2024 | |||
TCRR | TCR2 THERAPEUTICS INC. | President and CEO, Director | Jun 1, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|